Dario Blood Glucose Monitoring System - Android Devices User Performance Study Report
Completed · Not applicable
Conditions studied: Diabetes Mellitus
In brief
The purpose of this study is to evaluate the accuracy of the Dario Blood Glucose Monitoring System as compared to a reference method (Yellow Springs Instrument 2300 STAT Plus) and to evaluate the usability of the device when used by laypersons.
Key facts
- Study ID
- NCT02910674
- Run by
- LabStyle Innovations Ltd.
- People needed
- 102
- Starts
- 2016-07-01
- Expected to finish
- 2016-08-01
- Last updated by the study team
- 2021-04-13
Who can join
Age: 13 and older, up to 80. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Subject has Type 1 or Type II diabetes
- Subject speaks and reads English proficiently
- Subject is able and agrees to sign the informed consent form (minor subjects must be accompanied by a parent or legal guardian to provide consent for their participation in the study)
You may not qualify if…
- Subject has medical training or works in the field of blood glucose monitoring systems.
- Subject is critically ill.
- Subject has an impairment that prevents him/her from following the study procedures.
- Subject has any condition that the Principal Investigator believes may interfere in the subject's participation in the study.
- Hematocrit levels outside the range of 20%-60%.
Where it is running
- Barbara Davis Center — Aurora, Colorado, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.